2.4. Circulating NK Lymphocytes from CLL Subjects with Stable Disease Show Higher Expression of KIR2DS2 Activating Receptor and Significant Reduction of 3DL1 and NKG2A Inhibiting Molecules. Here, KLRC1 is linked to B-cell chronic lymphocytic leukemia.